Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a vaccine therapy in metastatic melanoma of the eye (intraocular/extrasocular extension), completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extraocular Extension Melanoma
• Intraocular Melanoma
• Melanoma of the Eye

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extraocular Extension Melanoma, Recurrent Intraocular Melanoma | Phase 2 | Status: COMPLETED